Upgrade to SI Premium - Free Trial

Pfizer (PFE) Reiterates at Neutral by Cantor Fitzgerald

June 1, 2026 8:02 AM
Cantor Fitzgerald analyst Carter Gould reiterated a Neutral rating and $27.00 price target on Pfizer (NYSE: PFE).The analyst commented, "Saturday ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments